antianginal (coronary active) drugs. ischemic heart disease 2,4 mln. people die from ihd annually
TRANSCRIPT
ISCHEMIC HEART DISEASEISCHEMIC HEART DISEASE
There are 35 risk factors for development of IHD 3 the most important ones are –
““big triplebig triple””
hypercholesterolemiahypercholesterolemia arterial hypertensionarterial hypertension
smokingsmoking
95 % of patients with IHD are observed to have atherosclerotic changes in coronary arteries
ANTIANGINALANTIANGINAL ( (CORONARY CORONARY ACTIVEACTIVE) ) DRUGSDRUGS
І. І. Nitrates and sidnonimins Nitrates and sidnonimins
ІІ. ІІ. BetaBeta--adrenoblockersadrenoblockers
ІІІ. ІІІ. Antagonists of calcium ionsAntagonists of calcium ions
ІУ. ІУ. Activators of potassium channelsActivators of potassium channels
• Inhibitors of ACE
• Platelet inhibitors and anticoagulants
• Drugs with metabolic influence on myocardium
NITRATESNITRATES
nitroglycerinnitroglycerin
isosorbidisosorbid dinitratedinitrate
isosorbidisosorbid-5--5-mononitratemononitrate
NITROGLYCERINENITROGLYCERINE
• TabletsTablets (under the tongue)• 1 % alcohol or oil solutionsolution (under the tongue)• aerosolaerosol
OnsetOnset - - 2-3 2-3 minmin
Duration of actionDuration of action - 20-30 - 20-30 minmin• ampoulesampoules 1 % solution – intravenously dropply
0,01% solution• prolongedprolonged forms of nitroglycerine: trinitrolong,
sustak, nitrong, ointment, plaster
NITROGLYCERINNITROGLYCERIN pharmaceutical formspharmaceutical forms
SIDE EFFECTS OF SIDE EFFECTS OF NITROGLYCERINENITROGLYCERINE
burstingbursting, , pulsating headachepulsating headache
decreasing of arterial pressuredecreasing of arterial pressure
((tachycardiatachycardia, , dizzinessdizziness, , collapsecollapse – – postural hypotensionpostural hypotension))
facial flushingfacial flushing, , feeling of feverfeeling of fever
Contraindications for Contraindications for nitroglycerine administrationnitroglycerine administration
• increasing of intracranial pressure, insult
• acute myocardial infarction (in case of presence of hypotonia and collapse)
PROLONGED FORMS OF PROLONGED FORMS OF NITROGLYCERINENITROGLYCERINE
• Trinitrolong – polymer films (0,001 g or 0,002 g of nitroglycerine) action develops immediately, lasts for 3-5 hours
• Sustac - Sustaс-mite (contains 0,0026 g of nitroglycerine) and Sustac-forte (0,0064 g of nitroglycerine)
onset – after 10 min, maximal action – after 1 hour, duration of action – 4-5 hours
• Nitrong – microcapsule form of nitroglycerine of prolonged action
onset – 30-60 min, maximal effect - after 3-4 hours,
Duration of action - 6-8 hours
Nitroglycerin and Premature BirthNitroglycerin and Premature Birth• The five-year, randomized check
involved 153 women selected at the time they went into pre-term labor (at 24 to 28 weeks).
• Employing nitroglycerin patches for pregnant women prolonged their pregnancy and what's new, the babies were born healthy, with less side effects than those induced by other drugs.
• In Canada, about 7.5 % of all babies are born prematurely (before 37 weeks) and 1 to 2 % are severe cases, before 34 weeks.
Other nitratesOther nitratesNitrosorbid Nitrosorbid – – isosorbid dinitrateisosorbid dinitrate
onset - 30-50 min, duration of action – 4-6 hours and more
With sublingual administration of the drug onset decreases to 3-5 min
• buccal form (Dinitrosorbilong)• tablets of prolonged action (Isoket-retard)
• ointment• aerosol
• drugs for intravenous introduction
IsosorbidIsosorbid-5--5-mononitratemononitrate - pharmacologically active metabolite of isosorbid dinitrate
duration of action - from 6 till 24 hours
SYDNONIMINSSYDNONIMINSMolsydomineMolsydomine – – corvatoncorvaton - - sydnopharmsydnopharm
• is metabolized by the liver forming a substance – SIN-1a which contains free NО group (doesn’t need
previous interaction with SH-groups) • nitric oxide stimulates guanylate cyclase that
activates synthesis of cGMP• cGMP causes dilation of vessels
2 2 mg of molsydominemg of molsydomine == 0,5 0,5 mg of nitroglycerinmg of nitroglycerin
BETA-ADRENOBLOCKERSBETA-ADRENOBLOCKERSMechanism of action during ischemic attackMechanism of action during ischemic attack
• blockade of 1-adrenoreceptors of heart: decrease of cardiac output and frequency of heart contractions and as follows cardiac need in oxygen
• decreasing of platelets aggregation and prevention of plug formation
• increasing duration of diastole – improvement of coronary vessels saturation with blood – improvement of perfusion of ischemic areas of myocardium
• Decreasing of calcium ions accumulation – releasing of cardiac muscle tension, improvement of metabolic processes, increasing of ATP synthesis
• in case of acute myocardium infarction – increasing of blood supply of ischemic areas of heart, decreasing of size of infarction area, prevention of development of cardiac arrhythmias
CALCIUM IONS ANTAGONISTSCALCIUM IONS ANTAGONISTS
1. Derivatives of difenilalkilamin (verapamil)2. Derivatives of benzothiazepine (dylthiazem)
3. Derivatives of dihydropyridine (nifedipin, amlodipin, nimodipin)
Drugs of 1 and 2 groups dominantly influence on heart (depress automatism of sinus node, slow cardiac conduction, decrease heart rate and oxygen demand), show antiarrhythmic, antianginal and hypotensive action
Derivatives of dihydropyridine (group of nifedipin) – decrease blood pressure and cause dilation of coronary vessels, cause reflective tachycardia
Antagonists of calcium ionsAntagonists of calcium ions – derivatives of dihydropyridine of ІІ ІІ generationgeneration (amlodipinamlodipin,
isradipin, nicardipin)
• don’t cause tachycardiadon’t cause tachycardia
• areare indicated for prolonged treatment of indicated for prolonged treatment of patients with stable anginapatients with stable angina
• Are not indicatedAre not indicated in case of unstable anginain case of unstable angina ((long onsetlong onset))
Hypertension Verapamil Dylthiazem Nifedipin Felodipin Amlodipin
Stenocardia Dylthiazem
Nifedipin Amlodipin Verapamil
Supraventricular tachy-arrhythmia
Verapamil Dylthiazem
Possible combination with β-blockers
Dylthiazem Nifedipin Amlodipin
-recommended drug --should be used carefully
Usage of calcium ions antagonistsUsage of calcium ions antagonists
Illness Drugs
Felodipin
ACTIVATORS OF POTASSIUM ACTIVATORS OF POTASSIUM CANALS CANALS
NICORANDILNICORANDIL
• activates Са2+-depending potassium channels• causes relaxation of smooth muscles of vessels – coronary, arteriolar and venous vasodilation • improves of blood supply of myocardium,
decreasing of pre- and afterloads of heart, decreasing of myocardial need in oxygen, of ischemic damage zone
Acetylsalicylic acid Acetylsalicylic acid 80-100 80-100 mg dailymg daily
• against platelets aggregationagainst platelets aggregation,, decreases risk of development of acute decreases risk of development of acute myocardium infarction and decreases myocardium infarction and decreases mortality of patients with IHDmortality of patients with IHD
• Throughout the world it is also used as Throughout the world it is also used as a drug for basic treatment of IHD (can a drug for basic treatment of IHD (can be used for years)be used for years)
• Main complication – gastric bleedingMain complication – gastric bleeding
ACUTE MYOCARDIAL ACUTE MYOCARDIAL INFARCTIONINFARCTION
From a 45-year-old man who died of an acute myocardial infarction. Postmortem serum Cholesterol 100 times more than normal.
cholesterol lowering drugscholesterol lowering drugs
Statins - HMG-Statins - HMG-CoA reductase CoA reductase
inhibitorsinhibitors
FibratesFibrates
Statins - HMG-CoA reductase Statins - HMG-CoA reductase inhibitorsinhibitors
• block the enzyme in the liver that is responsible block the enzyme in the liver that is responsible for making Cholesterol – for making Cholesterol – hydroxy-methylglutaryl-coenzyme reductase hydroxy-methylglutaryl-coenzyme reductase
• Statins lower Bad Cholesterol Levels, raise Statins lower Bad Cholesterol Levels, raise Good Cholesterol Levels, and can slow down Good Cholesterol Levels, and can slow down the formation of plaques in arteries. the formation of plaques in arteries.
• lower the chances of a heart attack and death in lower the chances of a heart attack and death in a group who have an elevated risk of a group who have an elevated risk of developing Heart Disease or who already have developing Heart Disease or who already have Heart DiseaseHeart Disease
Benefits of StatinsBenefits of Statins
• improving on the whole vascular functionimproving on the whole vascular function
• reduce the size of plaques in the arteriesreduce the size of plaques in the arteries
• stabilize plaques there by reducing the stabilize plaques there by reducing the chance of rupture and reduce chance of chance of rupture and reduce chance of acute heart attacksacute heart attacks
• reduce inflammation, believed to be an reduce inflammation, believed to be an important component of plaque formation important component of plaque formation and rupture.and rupture.
• Statin reduces CRP levelsStatin reduces CRP levels
Cholesterol-lowering “statin” drugs Cholesterol-lowering “statin” drugs side effectsside effects
• fatigue• muscle pain (9 % of patients) • at higher doses and long term administration –
myopathy (rhabdomyolysis) acute damage to muscle tissue - can be very serious
• reduced proliferation• damage to kidneys• increased risk for cataracts• elevated blood sugar• increased risk for prostate and breast cancer
Fibrates complicationsFibrates complications
• Nausea, diarrhea and abdominal pain
• Renal insufficiency
• Rhabdomyolysis
• Hypersensitivity, rash
• formation of gallstones
Nicotinic acid or niacinNicotinic acid or niacin
useful for patients with mixed dyslipidemias
inhibits transport of free fatty acids to the liver from peripheral adipose tissue resulting in decreased triglyceride synthesis
increases in HDL cholesterol and decreases in VLDL and LDL cholesterol
for diabetic dyslipidemia to increase HDL cholesterol